Aptamer Sciences Inc (KOSDAQ:291650)
1,705.00
-52.00 (-2.96%)
At close: Apr 28, 2026
Aptamer Sciences Market Cap
Aptamer Sciences has a market cap or net worth of 68.64 billion as of April 28, 2026. Its market cap has increased by 147.02% in one year.
Market Cap
68.64B
Enterprise Value
59.17B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1,705.00
Market Cap Chart
Since September 16, 2020, Aptamer Sciences's market cap has decreased from 234.93B to 68.64B, a decrease of -70.78%. That is a compound annual growth rate of -19.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 68.64B | 124.93% |
| Dec 30, 2025 | 30.51B | -4.74% |
| Dec 30, 2024 | 32.03B | -47.67% |
| Dec 28, 2023 | 61.21B | -17.60% |
| Dec 29, 2022 | 74.29B | -48.53% |
| Dec 30, 2021 | 144.35B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Choong Ang Vaccine Laboratory | 92.79B |
| Quratis | 92.47B |
| Shaperon | 86.57B |
| Naturalendo Tech | 86.20B |
| PanGen Biotech | 83.66B |
| IMGT Co.,Ltd. | 78.37B |
| Progen | 76.49B |
| Psomagen | 72.62B |